158 related articles for article (PubMed ID: 20942912)
1. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.
Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K
Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of chondrosarcoma.
Jeong W; Kim HJ
J Clin Pathol; 2018 Jul; 71(7):579-583. PubMed ID: 29593061
[TBL] [Abstract][Full Text] [Related]
4. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
5. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
7. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
9. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
[TBL] [Abstract][Full Text] [Related]
10. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
12. MR differentiation of low-grade chondrosarcoma from enchondroma.
Choi BB; Jee WH; Sunwoo HJ; Cho JH; Kim JY; Chun KA; Hong SJ; Chung HW; Sung MS; Lee YS; Chung YG
Clin Imaging; 2013; 37(3):542-7. PubMed ID: 23041161
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma.
Yapar A; Ulucaköy C; Sezgin EA; Atalay İB; Ekşioğlu MF
Jt Dis Relat Surg; 2020; 31(2):286-290. PubMed ID: 32584727
[TBL] [Abstract][Full Text] [Related]
15. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
16. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
[TBL] [Abstract][Full Text] [Related]
17. Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?
Roitman PD; Farfalli GL; Ayerza MA; Múscolo DL; Milano FE; Aponte-Tinao LA
Clin Orthop Relat Res; 2017 Mar; 475(3):808-814. PubMed ID: 26883651
[TBL] [Abstract][Full Text] [Related]
18. A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.
Welkerling H; Kratz S; Ewerbeck V; Delling G
Virchows Arch; 2003 Dec; 443(6):725-33. PubMed ID: 14513378
[TBL] [Abstract][Full Text] [Related]
19. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].
Welkerling H; Werner M; Delling G
Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative diagnosis and histopathologic grading of chondrosarcoma].
Li JP
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):391-3. PubMed ID: 8174490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
